A natural tetranortriterpenoid with immunomodulating properties as a potential anti-HSV agent

Virus Research

Volumn 141, Issue 1, 2009, Pages 47-54

  Bueno, Carlos A ^a   Barquero, Andrea A ^a   Di Cónsoli, Hernán ^a   Maier, Marta S ^a   Alché, Laura E ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Antiviral; Cytokine; HSV; Immunomodulatory; Medicinal plants; NF B

Indexed keywords

1 CINNAMOYL 3,11 DIHYDROXYMELIACARPIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TRITERPENOID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CORNEA CELL; CYTOKINE RELEASE; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IMMUNOMODULATION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CELLS, CULTURED; CORNEA; CYTOKINES; HERPESVIRUS 1, HUMAN; HUMANS; KERATITIS, HERPETIC; LIMONINS; MACROPHAGES; MELIA AZEDARACH; MICE;

HUMAN HERPESVIRUS 1; MELIA AZEDARACH; MURINAE; MUS; SIMPLEXVIRUS;

EID: 61749086046     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2008.12.013     Document Type: Article

References (32)

1. Alché L.E., Assad Ferek G., Meo M., Coto C.E., and Maier M.S. An antiviral meliacarpin from leaves of Melia azedarach L. Z. Naturforsch. 58c (2003) 215-219
2. Arena A., Bisignano G., Pavone B., Tomaino A., Bonina F.P., Saija A., Cristani M., D'Arrigo M., and Trombetta D. Antiviral and immunomodulatory effect of a lyophilized extract of Capparis spinosa L. buds. Phytother. Res. 22 (2008) 313-317
3. Barquero A.A., Alché L.E., and Coto C.E. Block of vesicular stomatitis virus endocytic and exocytic pathways by 1-cinnamoyl-3, 11-dihydroxymeliacarpin, a tetranortriterpenoid of natural origin. J. Gen. Virol. 85 (2004) 483-493
4. Barquero A.A., Michelini F.M., and Alché L.E. 1-cinnamoyl-3,11-dihydroxymeliacarpin is a natural compound with antiviral and nuclear factor-κB modulating properties. Biochem. Biophys. Res. Co. 344 (2006) 955-962
5. Bauer D., Schmitz A., Van Rooijen N., Steuhl K., and Heiligenhaus A. Conjunctival macrophage-mediated influence of the local and systemic immune response after corneal herpes simplex virus-1 infection. Immunology 107 (2002) 118-128
6. Biswas P.S., and Rouse B.T. Early events in HSV keratitis-setting the stage for a blinding disease. Microbes Infect. 7 (2005) 799-810
7. Biswas P., Banerjee K., Kinchington P., and Rouse B. Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection. Exp. Eye Res. 82 (2006) 46-54
8. Chattopadhyay D., and Naik T.N. Antivirals of ethnomedicinal origin: structure-activity relantionship and scope. Mini-Rev. Med. Chem. 7 (2007) 275-301
9. Chen J.L., Kernan M.R., Jolad S.D., Stoddart C.A., Bogan M., and Cooper R. Dysoxylins A-D, tetranortriterpenoids with potent anti-rsv activity from Dysoxylum gaudichaudianum. J. Nat. Prod. 70 (2007) 312-315
10. Chiang L.C., Ng L.T., Chiang W., Chang M.Y., and Lin C.C. Immunomodulatory activities of flavonoids, monoterpenoids, triterpenoids, iridoid glycosides and phenolic compounds of Plantago species. Planta Med. 69 (2003) 600-604
11. Decker T., Lohmann-Mathess M.L., and Gifford G.E. Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages. J. Immunol. 138 (1987) 957-962
12. Denizot F., and Lang R. Rapid colorimetric assay for cell growth and survival. J. Immunol. Methods 89 (1986) 271-277
13. Deshpande S., Banerjee K., Biswas P.S., and Rouse B.T. Herpetic eye disease: immunopathogenesis and therapeutic measures. Expert Rev. Mol. Med. 2004 (2004) 1-14
14. Diao L., Zhang B., Xuan C., Sun S., Yang K., Tang Y., Qiao W., Chen Q., Geng Y., and Wang C. Activation of c-Jun N-terminal kinase (JNK) pathway by HSV-1 immediate early protein ICP0. Exp. Cell Res. 308 (2005) 196-210
15. Fujita S., Saika S., Kao W.W., Fujita K., Miyamoto T., Ikeda K., Nakajima Y., and Ohnishi Y. Endogenous TNF alpha suppression of neovascularization in corneal stroma in mice. Invest. Ophthalmol. Vis. Sci. 48 (2007) 3051-3055
16. Gregory D., Hargett D., Holmes D., Money E., and Bachenheimer S. Efficient replication by herpes simplex virus type 1 involves activation of the IkappaB kinase-IkappaB-p65 pathway. J. Virol. 78 (2004) 13582-13590
17. Hiscott J., Kwon H., and Genin P. Hostile takeovers: viral appropriation of the NF-kappaB pathway. J. Clin. Invest. 107 (2001) 143-151
18. Joycharat N., Greger H., Hofer O., and Saifah E. Flavaglines and triterpenoids from the leaves of Aglaia forbesii. Phytochemistry 69 (2008) 206-211
19. Kase S., Aoki K., Harada T., Harada C., Ohgami K., Shiratori K., Nishi S., Ohno S., and Yoshida K. Activation of nuclear factor-kappa B in conjunctiva with epithelial scraping of the Mouse cornea and human epidemia keratoconjunctivitis. Br. J. Ophtalmol. 88 (2004) 947-949
20. Li H., Zhang J., Kumar A., Zheng M., Atherton S.S., and Yu F.X. Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells. Immunology 117 (2005) 167-176
21. Manners G. Citrus limonoids: analysis, bioactivity, and biomedical prospects. J. Agric. Food Chem. 55 (2007) 8285-8294
22. Melchjorsen J., Sirén J., Julkunen I., Paludan S., and Matikainen S. Induction of cytokine expression by herpes simplex virus in human monocyte-derived macrophages and dendritic cells is dependent on virus replication and is counteracted by ICP27 targeting NF-kappaB and IRF-3. J. Gen. Virol. 87 (2006) 1099-1108
23. Michelini F.M., Berra A., and Alché L.E. The in vitro immunomodulatory activity of a synthetic brassinosteroid analogue World account for the improvement of herpetic stromal keratitis in mice. J. Steroid. Biochem. 108 (2007) 164-170
24. Mott K., Brick D.J., van Rooijen N., and Ghiasi H. Macrophages are important determinants of acute ocular HSV-1 infection in immunized mice. Invest. Ophthalmol. Vis. Sci. 48 (2007) 5605-5615
25. Mukhtar M., Arshad M., Ahmad M., Pomerantz R.J., Wigdahl B., and Parveen Z. Antiviral potentials of medicinal plants. Virus Res. 131 (2008) 111-120
26. Nam N. Naturally occurring NF-κB inhibitors. Mini-Rev. Med. Chem. 6 (2006) 945-951
27. Petrera E., and Coto C.E. Effect of meliacine, a plant derived antiviral, on tumor necrosis factor alpha. Fitoterapia 74 (2003) 77-83
28. Pifarré M.P., Berra A., Coto C.E., and Alché L.A. Therapeutic action of Meliacine, a plant-derived antiviral, on HSV-induced ocular disease in mice. Exp. Eye Res. 75 (2002) 327-334
29. Santoro M.G., Rossi A., and Amici C. NF-kappaB and virus infection: who controls whom. EMBO J. 22 (2003) 2552-2560
30. +-ATPase in interferon-induced inhibition of viral glycoprotein transport. J. Interferon Cytokine Res. 19 (1999) 1297-1303
31. Wen C., Kuo Y., Jan J., Liang P., Wang S., Liu H., Lee C., Chang S., Kuo C., Lee S., Hou C., Hsiao P., Chien S., Shyur L., and Yang N. Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. J. Med. Chem. 50 (2007) 4087-4095
32. Zachos G., Clements B., and Conner J. Herpes simplex virus type 1 infection stimulates p38/c-Jun N-terminal mitogen-activated protein kinase pathways and activates transcription factor AP-1. J. Biol. Chem. 274 (1999) 5097-5103